Popat R, Warcel D, O’Nions J, Cowley A, Smith S, Tucker WR, Yong K, Degli Esposti S. Characterization of response and corneal events with extended follow-up after belantamab mafodotin (GSK2857916) monotherapy for patients with relapsed multiple myeloma: a case series from the first-time-in-human clinical trial. Haematologica 2020; 105(5):e261-e263; https://doi.org/10.3324/haematol.2019.235937.